Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1082133

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Tackling Antimicrobial Resistance Action Plan 2019-2024, how delinking the price paid for antimicrobials from the volume sold will ensure that products produced by industry are affordable to the NHS.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	228682
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>The 2016 United Nations political declaration on antimicrobial resistance (AMR) acknowledged the importance of delinking the cost of investment in research and development on AMR from the price and volume of sales to facilitate equitable and affordable access to new products and encouraged governments to explore innovative approaches.</p><p> </p><p>It is critical that the National Health Service makes the best use of its resources. Any payment model must therefore be based on a robust evaluation of the value that a new antimicrobial product brings to patients and the public as a whole. The assessment of how much value a new antibiotic brings is highly complex and will vary considerably from one product to another.</p><p> </p><p>In the United Kingdom, NHS England and the National Institute for Health and Care Excellence (NICE) are leading work to test innovative models that pay companies based primarily on a NICE led health technology assessment of their value to the NHS as opposed to the volumes used. This has the potential to both promote good antimicrobial stewardship and provide a much-needed incentive for the development of new antimicrobial agents that will, over time, provide value for the NHS.</p><p> </p><p>The test will be subject to robust evaluation before considering any wider change to purchasing policy. The UK represents only a small part of the global market for these drugs and we want to send a signal to the rest of the world that there are workable models to achieve the right sort of incentives for these vital medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 228683 question first answered 11/03/2019 18:32:38 answering member 4067 label Biography information for Steve Brine previous answer version 106924 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4385 label Biography information for Dr Philippa Whitford

1082134

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of using models that de-link the cost of research and development from the price of the final product and the volume of sales, as set out in the 2016 UN Political Declaration of the High-Level Meeting of the General Assembly on antimicrobial resistance, to ensure that new diagnostics, medicines and tools created are accessible and affordable.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	228683
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>The 2016 United Nations political declaration on antimicrobial resistance (AMR) acknowledged the importance of delinking the cost of investment in research and development on AMR from the price and volume of sales to facilitate equitable and affordable access to new products and encouraged governments to explore innovative approaches.</p><p> </p><p>It is critical that the National Health Service makes the best use of its resources. Any payment model must therefore be based on a robust evaluation of the value that a new antimicrobial product brings to patients and the public as a whole. The assessment of how much value a new antibiotic brings is highly complex and will vary considerably from one product to another.</p><p> </p><p>In the United Kingdom, NHS England and the National Institute for Health and Care Excellence (NICE) are leading work to test innovative models that pay companies based primarily on a NICE led health technology assessment of their value to the NHS as opposed to the volumes used. This has the potential to both promote good antimicrobial stewardship and provide a much-needed incentive for the development of new antimicrobial agents that will, over time, provide value for the NHS.</p><p> </p><p>The test will be subject to robust evaluation before considering any wider change to purchasing policy. The UK represents only a small part of the global market for these drugs and we want to send a signal to the rest of the world that there are workable models to achieve the right sort of incentives for these vital medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 228682 question first answered 11/03/2019 18:32:38 answering member 4067 label Biography information for Steve Brine previous answer version 106925 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4385 label Biography information for Dr Philippa Whitford

1082141

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: ICT
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NHS login is fully tested and fit for launch.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	228688
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>NHS Digital has advised that the National Health Service login service is currently being rigorously user tested to ensure that it is accessible, trusted and valued before being made available more widely.</p><p> </p><p>The NHS login service has been developed following iterative and agile delivery methods to ensure that user research, enhancements and security testing are continuously conducted, and software releases are rapid, controlled and monitored. Each change into a live environment is independently approved against information governance, security and clinical standards and risk assessments.</p><p> </p><p>The service is constantly monitored and tested to ensure that it can predict and mitigate security threats and vulnerabilities.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 11/03/2019 14:30:59 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4425 label Biography information for Jo Stevens

1082160

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Carbon Monoxide: Poisoning
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans does his Department has for improving health outcomes for people with long-term cognitive and behavioural difficulties caused by carbon monoxide poisoning.
tabling member constituency	Rhondda
tabling member printed	Chris Bryant
uin	228595
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>I would be happy to meet with the Rt. hon. Member for Rhondda and campaigners to discuss improving outcomes for those with brain injury caused by carbon monoxide poisoning.</p><p> </p><p>NHS England has issued ‘Commissioning Guidance for Rehabilitation’ which provides a framework for commissioners to use service information, and a benchmarking tool, to specifically support reduction of variation in access to and quality of rehabilitation services. This is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2016/04/rehabilitation-comms-guid-16-17.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2016/04/rehabilitation-comms-guid-16-17.pdf</a></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 228596 question first answered 11/03/2019 17:22:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1446 label Biography information for Sir Chris Bryant

1082161

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Carbon Monoxide: Poisoning
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will meet with campaigners and the Rt Hon. Member for Rhondda to discuss reviewing provision of neurorehabilitation services throughout the country, particularly in cases of brain injury caused by carbon monoxide poisoning.
tabling member constituency	Rhondda
tabling member printed	Chris Bryant
uin	228596
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>I would be happy to meet with the Rt. hon. Member for Rhondda and campaigners to discuss improving outcomes for those with brain injury caused by carbon monoxide poisoning.</p><p> </p><p>NHS England has issued ‘Commissioning Guidance for Rehabilitation’ which provides a framework for commissioners to use service information, and a benchmarking tool, to specifically support reduction of variation in access to and quality of rehabilitation services. This is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2016/04/rehabilitation-comms-guid-16-17.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2016/04/rehabilitation-comms-guid-16-17.pdf</a></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 228595 question first answered 11/03/2019 17:22:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1446 label Biography information for Sir Chris Bryant

1082169

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Parking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what consultation his Department has undertaken on the level and appropriateness of parking fines on issued in NHS hospital car parks.
tabling member constituency	North West Durham
tabling member printed	Laura Pidcock
uin	228785
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>The Department has not consulted on the appropriateness of parking fines issued in National Health Service hospital car parks.</p><p> </p><p>The level and appropriateness of car parking charges at NHS sites is the responsibility of the local NHS trust. As set out in the NHS Car Parking Principles we have always made clear that staff, patients and their families should not have to deal with the stress of complex and unfair charges. These were based on discussions with interested parties including NHS trusts and patients’ organisations.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 11/03/2019 17:14:53 answering member 1585 label Biography information for Stephen Hammond
tabling member	4665 label Biography information for Laura Pidcock

1082177

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lyme Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many requests for research funding into Lyme Disease have been submitted to National Institute for Health Research health protection research units; how many of those applications have been approved; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	228549
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>The Department commissions research through the National Institute for Health Research (NIHR) and is the largest public funder of health research in the United Kingdom. The NIHR welcomes funding applications for research into any aspect of human health, including Lyme disease. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.</p><p> </p><p>The NIHR currently has no current applications for research on Lyme disease. The NIHR Health Protection Research Unit on Emerging and Zoonotic Infections is undertaking work on Lyme disease including looking at incidence of the disease in England and Wales.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/03/2019 17:07:46 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	253 label Biography information for Mr Laurence Robertson

1082185

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lyme Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of advances in the abilities of medical practitioners to diagnose Lyme Disease; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	228550
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Individual medical schools set undergraduate medical training curricula and the relevant Royal Colleges set postgraduate medical training curricula which have to meet the standards set by the General Medical Council. Curricula should emphasise the skills and approaches that a doctor must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients.</p><p><strong> </strong></p><p>The National Institute for Health and Care Excellence (NICE) published updated guidance in 2018 on the diagnoses and management of Lyme disease, which can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ng95" target="_blank">https://www.nice.org.uk/guidance/ng95</a></p><p> </p><p>The guidance aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. NICE’s guidelines help health and care professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although health and care commissioners are expected to take them fully into account. In addition, in February 2019, NICE published the following article at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/news/article/diagnose-lyme-disease-if-bull-s-eye-rash-is-present-says-nice" target="_blank">https://www.nice.org.uk/news/article/diagnose-lyme-disease-if-bull-s-eye-rash-is-present-says-nice</a></p><p> </p><p>Public Health England published guidance on Lyme disease in July 2018, which describes the clinical signs and symptoms of Lyme disease and is consistent with the NICE guidance. The guidance can be found at the folloiwng link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/lyme-disease-guidance-data-and-analysis" target="_blank">https://www.gov.uk/government/collections/lyme-disease-guidance-data-and-analysis</a></p><p> </p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 228551 question first answered 11/03/2019 18:29:30 answering member 4067 label Biography information for Steve Brine previous answer version 106916 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	253 label Biography information for Mr Laurence Robertson

1082191

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lyme Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what training is given to medical practitioners to enable them to (a) recognise the symptoms of and (b) treat Lyme Disease; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	228551
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Individual medical schools set undergraduate medical training curricula and the relevant Royal Colleges set postgraduate medical training curricula which have to meet the standards set by the General Medical Council. Curricula should emphasise the skills and approaches that a doctor must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients.</p><p><strong> </strong></p><p>The National Institute for Health and Care Excellence (NICE) published updated guidance in 2018 on the diagnoses and management of Lyme disease, which can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ng95" target="_blank">https://www.nice.org.uk/guidance/ng95</a></p><p> </p><p>The guidance aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. NICE’s guidelines help health and care professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although health and care commissioners are expected to take them fully into account. In addition, in February 2019, NICE published the following article at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/news/article/diagnose-lyme-disease-if-bull-s-eye-rash-is-present-says-nice" target="_blank">https://www.nice.org.uk/news/article/diagnose-lyme-disease-if-bull-s-eye-rash-is-present-says-nice</a></p><p> </p><p>Public Health England published guidance on Lyme disease in July 2018, which describes the clinical signs and symptoms of Lyme disease and is consistent with the NICE guidance. The guidance can be found at the folloiwng link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/lyme-disease-guidance-data-and-analysis" target="_blank">https://www.gov.uk/government/collections/lyme-disease-guidance-data-and-analysis</a></p><p> </p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 228550 question first answered 11/03/2019 18:29:30 answering member 4067 label Biography information for Steve Brine previous answer version 106918 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	253 label Biography information for Mr Laurence Robertson

1082240

registered interest
date	05/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sanitary Products: Educational Institutions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking with the Department for Education to provide free sanitary products in (a) secondary schools, (b) colleges and (c) universities.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	228707
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Provision of sanitary products in schools, colleges, and universities is a matter for the Department for Education.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 11/03/2019 14:29:58 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4656 label Biography information for Layla Moran